In vivo mouse experiments revealed that macrophages exhibited elevated glycolysis and that macrophage-specific deletion of GLUT-1 reduced tumor burden by increasing natural killer and CD8+ T cell activity and suppressing the inflammatory state [38]. The gene discussed is CD8A; the disease is neoplasm.